Predictive Oncology Free Cash Flow 2010-2023 | POAI
Predictive Oncology free cash flow from 2010 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Predictive Oncology Annual Free Cash Flow | |
|---|---|
| 2023 | -13.47 |
| 2022 | -12.79 |
| 2021 | -13.12 |
| 2020 | -12.36 |
| 2019 | -8.74 |
| 2018 | -5.47 |
| 2017 | -4.51 |
| 2016 | -4.41 |
| 2015 | -7.52 |
| 2014 | -3.47 |
| 2013 | -4.02 |
| 2012 | -1.18 |
| 2011 | -1.78 |
| 2010 | -0.82 |
| 2009 | -1.31 |
| Predictive Oncology Quarterly Free Cash Flow | |
|---|---|
| 2023-12-31 | -13.47 |
| 2023-09-30 | -10.39 |
| 2023-06-30 | -7.28 |
| 2023-03-31 | -3.45 |
| 2022-12-31 | -12.79 |
| 2022-09-30 | -9.50 |
| 2022-06-30 | -6.66 |
| 2022-03-31 | -3.14 |
| 2021-12-31 | -13.12 |
| 2021-09-30 | -9.18 |
| 2021-06-30 | -6.14 |
| 2021-03-31 | -3.71 |
| 2020-12-31 | -12.36 |
| 2020-09-30 | -9.93 |
| 2020-06-30 | -6.59 |
| 2020-03-31 | -2.97 |
| 2019-12-31 | -8.74 |
| 2019-09-30 | -5.94 |
| 2019-06-30 | -4.05 |
| 2019-03-31 | -2.05 |
| 2018-12-31 | -5.47 |
| 2018-09-30 | -4.24 |
| 2018-06-30 | -3.24 |
| 2018-03-31 | -1.73 |
| 2017-12-31 | -4.51 |
| 2017-09-30 | -3.18 |
| 2017-06-30 | -2.11 |
| 2017-03-31 | -1.18 |
| 2016-12-31 | -4.41 |
| 2016-09-30 | -3.73 |
| 2016-06-30 | -2.80 |
| 2016-03-31 | -1.61 |
| 2015-12-31 | -7.52 |
| 2015-09-30 | -4.64 |
| 2015-06-30 | -0.22 |
| 2015-03-31 | -0.01 |
| 2014-12-31 | -3.47 |
| 2014-09-30 | -3.25 |
| 2014-06-30 | -2.02 |
| 2014-03-31 | -1.83 |
| 2013-12-31 | -4.02 |
| 2013-09-30 | -3.39 |
| 2013-06-30 | -2.13 |
| 2013-03-31 | -0.94 |
| 2012-12-31 | -1.18 |
| 2012-09-30 | -0.78 |
| 2012-06-30 | -0.64 |
| 2012-03-31 | -0.25 |
| 2011-12-31 | -1.78 |
| 2011-09-30 | -1.19 |
| 2011-06-30 | -0.81 |
| 2011-03-31 | -0.37 |
| 2010-12-31 | -0.82 |
| 2010-09-30 | -0.77 |
| 2010-06-30 | -0.54 |
| 2010-03-31 | -0.30 |
| 2009-12-31 | -1.31 |
| 2009-09-30 | -0.99 |
| 2009-06-30 | -0.71 |
| 2009-03-31 | -0.34 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.755B | 20.18 |
| Inspire Medical Systems (INSP) | United States | $4.712B | 0.00 |
| Axonics (AXNX) | United States | $3.441B | 0.00 |
| 10x Genomics (TXG) | United States | $3.165B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.092B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.951B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.949B | 0.00 |
| Enovis (ENOV) | United States | $2.880B | 21.34 |
| Azenta (AZTA) | United States | $2.763B | 155.30 |
| Privia Health (PRVA) | United States | $2.154B | 120.33 |
| Schrodinger (SDGR) | United States | $1.690B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 48.06 |
| Phreesia (PHR) | United States | $1.251B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.668B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.643B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.505B | 0.00 |
| Talkspace (TALK) | United States | $0.484B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.404B | 0.00 |
| Pulmonx (LUNG) | United States | $0.346B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.303B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.212B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.207B | 0.00 |
| Outset Medical (OM) | United States | $0.181B | 0.00 |
| American Well (AMWL) | United States | $0.148B | 0.00 |
| TruBridge (TBRG) | United States | $0.132B | 7.10 |
| MSP Recovery (LIFW) | United States | $0.113B | 0.00 |
| 111 (YI) | China | $0.110B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.073B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.068B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.063B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| Movano (MOVE) | United States | $0.041B | 0.00 |
| Akili (AKLI) | United States | $0.035B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| CareCloud (CCLD) | United States | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Syra Health (SYRA) | United States | $0.011B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |